End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.35 TWD | 0.00% | +1.55% | -6.03% |
Apr. 19 | InnoPharmax Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | InnoPharmax Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 29.13M 904K | Sales 2023 | 46.07M 1.43M | Capitalization | 1.65B 51.3M |
---|---|---|---|---|---|
Net income 2022 | -103M -3.2M | Net income 2023 | -70M -2.17M | EV / Sales 2022 | 32.6 x |
Net cash position 2022 | 67.02M 2.08M | Net cash position 2023 | 118M 3.67M | EV / Sales 2023 | 33.3 x |
P/E ratio 2022 |
-9.83
x | P/E ratio 2023 |
-22.6
x | Employees | 34 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.83% |
1 week | +1.55% | ||
Current month | +9.73% | ||
1 month | +10.85% | ||
3 months | -4.39% | ||
6 months | -28.45% | ||
Current year | -6.03% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Hua Hao
CEO | Chief Executive Officer | - | - |
Ssu Ju Chen
DFI | Director of Finance/CFO | - | 22-02-28 |
Yu Tsai Yang
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Hui Lin
CHM | Chairman | - | - |
Wei Hua Hao
CEO | Chief Executive Officer | - | - |
Han Pin Kuo
BRD | Director/Board Member | - | 12-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 16.35 | 0.00% | 198,228 |
24-05-17 | 16.35 | -0.91% | 154,820 |
24-05-16 | 16.5 | +0.92% | 138,263 |
24-05-15 | 16.35 | -1.51% | 349,440 |
24-05-14 | 16.6 | +3.11% | 454,879 |
End-of-day quote Taipei Exchange, May 19, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-6.03% | 48.23M | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+15.65% | 5.63B |
- Stock Market
- Equities
- 4172 Stock